Endometrial Cancer | Practical Considerations Surrounding the Use of Immune Checkpoint Inhibitors in the Management of Endometrial Cancer

published 4 months ago by Dr Neil Love

Featuring perspectives from Drs Gottfried E Konecny, Mansoor Raza Mirza and Brian M Slomovitz on the following topics: Systemic Therapy in Endometrial Cancer: Is Immunotherapy Active? — Gottfried E Konecny, MD, MS (0:00) Approved and Investigational Immunotherapeutic Approaches for Microsatellite-Stable (MSS) Endometrial Cancer — Mansoor Raza Mirza, MD (39:55) Recognition and Management of Toxicities with the Use of Immune Checkpoint Inhibitor-Based Therapy in Advanced Endometrial Cancer — Gottfried E Konecny, MD (1:15:53) CME information and select publications

more episodes from Research To Practice | Oncology Videos